Provizigen Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Provizigen General Information

Description

Operator of a biotherapeutic technology company intended to repair injured tissue and prevent further degeneration. The company develops an injectable hydrogel intended to support tissue repair and joint recovery without invasive surgical procedures, enabling patients with joint injuries to improve recovery while reducing the need for surgical intervention.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 111 4TH Avenue
  • Suite 2M
  • New York, NY 10003-5245
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 111 4TH Avenue
  • Suite 2M
  • New York, NY 10003-5245
  • United States

Provizigen Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Provizigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 04-Feb-2025 Completed Startup
3. Grant 01-Jan-2024 Completed Startup
2. Grant 01-Jan-2024 $275K Completed Startup
1. Grant 25-Sep-2023 $351K Completed Startup
To view Provizigen’s complete valuation and funding history, request access »

Provizigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provizigen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Westchester County Biosciences Accelerator Accelerator/Incubator
US National Science Foundation Accelerator/Incubator
U.S. Department of Health and Human Services Government
To view Provizigen’s complete investors history, request access »

Provizigen FAQs

  • When was Provizigen founded?

    Provizigen was founded in 2022.

  • Where is Provizigen headquartered?

    Provizigen is headquartered in New York, NY.

  • What is the size of Provizigen?

    Provizigen has 2 total employees.

  • What industry is Provizigen in?

    Provizigen’s primary industry is Biotechnology.

  • Is Provizigen a private or public company?

    Provizigen is a Private company.

  • What is Provizigen’s current revenue?

    The current revenue for Provizigen is .

  • Who are Provizigen’s investors?

    Westchester County Biosciences Accelerator, US National Science Foundation, and U.S. Department of Health and Human Services have invested in Provizigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process